Noevir Holdings Co Ltd
TSE:4928
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4 760
5 870
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Noevir Holdings Co Ltd
Noevir Holdings Co Ltd
Other Current Liabilities
Noevir Holdings Co Ltd
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Noevir Holdings Co Ltd
TSE:4928
|
Other Current Liabilities
¥6.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-1%
|
|
|
Shiseido Co Ltd
TSE:4911
|
Other Current Liabilities
¥112.2B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
3%
|
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Other Current Liabilities
¥37.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
22%
|
CAGR 10-Years
13%
|
|
|
Kao Corp
TSE:4452
|
Other Current Liabilities
¥184.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
0%
|
|
|
Kose Corp
TSE:4922
|
Other Current Liabilities
¥22B
|
CAGR 3-Years
14%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Other Current Liabilities
¥23.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
3%
|
|
Noevir Holdings Co Ltd
Glance View
In the versatile world of beauty and wellness, Noevir Holdings Co Ltd. stands as a testament to astute innovation combined with a well-honed business acumen. Founded in Japan, this company has expertly navigated the delicate balance of tradition and modernity to emerge as a prominent figure in the skincare and cosmetic industries. Noevir's strategy is rooted in the meticulous formulation of its products, drawing inspiration from natural ingredients, which reflects the company’s keen attention to quality and detail. By leveraging advanced research and development techniques, Noevir crafts a diverse range of skincare and personal care products designed to cater to the discerning needs of its clientele. They operate primarily through direct sales channels, allowing them to maintain a personal relationship with their customers, understanding their preferences deeply and ensuring a consistent brand experience. Financially, Noevir Holdings generates revenue by employing a multi-faceted business model, anchoring itself in both domestic and international markets. Besides its leading role in the cosmetics sector, the company diversifies through its involvement in pharmaceuticals and health foods, broadening its portfolio to mitigate market risks. This diversity not only stabilizes the company’s revenue streams but also aligns with the increasing consumer emphasis on holistic health and wellness solutions. Noevir's ability to anticipate and respond to market trends ensures its growth trajectory, having firmly established its brand in the Asian market while progressively expanding its footprint across regions. As a result, the company's strategy encompasses not just product innovation but also a robust marketing and distribution network that reinforces its position as a leader in the beauty and wellness industry.
See Also
What is Noevir Holdings Co Ltd's Other Current Liabilities?
Other Current Liabilities
6.2B
JPY
Based on the financial report for Sep 30, 2024, Noevir Holdings Co Ltd's Other Current Liabilities amounts to 6.2B JPY.
What is Noevir Holdings Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
-1%
Over the last year, the Other Current Liabilities growth was -17%. The average annual Other Current Liabilities growth rates for Noevir Holdings Co Ltd have been 2% over the past three years , -2% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
